Intrapatient Variability (IPV) and the Blood Concentration Normalized by the Dose (C/D Ratio) of Tacrolimus—Their Correlations and Effects on Long-Term Renal Allograft Function
Open Access
- 8 November 2022
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 10 (11) , 2860
Abstract
Tacrolimus, in combination with mycophenolate mofetil and glucocorticoids, is the basis of immunosuppressive therapy after renal transplantation. Tacrolimus intrapatient variability (IPV) and the blood concentration normalized by the dose (concentration/dose ratio, C/D ratio) both have an effect on the function of the transplanted kidney. In this study, we examined whether the metabolism rate affected IPV, whether the C/D ratio value was stable in the long-term follow-up, and whether it could be used for IPV measurements. In addition, our study population was examined for the effect of the C/D ratio and IPV on long-term renal function. The C/D ratio and IPV were examined in 170 patients at appointments held at 3, 6, 12 and 24 months after RTx. The average time post renal transplantation was 70 months. Renal function defined as creatinine concentration at the last appointment was examined. Results: the mean C/D ratio in the study group was 1.63. A negative correlation between the C/D ratio and creatinine concentration at the end of the follow-up was observed. Between the C/D ratio < and ≥1.63 groups, significant differences in creatinine concentration at the last appointment were found. No relationship was identified between the mean C/D ratio and IPV. The C/D ratio values increased significantly over a longer post-transplant period (12, 24, 60 and 120 m). We did not find a correlation between the mean IPV and the creatinine concentration from the last appointment. Our study group was divided into terciles according to IPV, while no renal graft function differences were found at the same appointment. Conclusion: the C/D ratio is useful for assessing the effects of the metabolism rate of tacrolimus on the long-term renal graft function. The C/D ratio does not affect the IPV value. IPV calculated from variability of the C/D ratio does not influence transplanted kidney function. The C/D changes over time.Keywords
Funding Information
- Ministry of Science and Higher Education in the “Regional initiative of excellence” program (002/RID/2018/19.)
This publication has 20 references indexed in Scilit:
- Impact of Tacrolimus Intraindividual Variability and CYP3A5 Genetic Polymorphism on Acute Rejection in Kidney TransplantationTherapeutic Drug Monitoring, 2012
- Identification of Factors Affecting Tacrolimus Level and 5‐Year Clinical Outcome in Kidney Transplant PatientsBasic & Clinical Pharmacology & Toxicology, 2012
- Long-Term Renal Allograft Survival in the United States: A Critical ReappraisalAmerican Journal of Transplantation, 2011
- Impact of Subclinical Inflammation on the Development of Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant RecipientsAmerican Journal of Transplantation, 2010
- High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantationNephrology Dialysis Transplantation, 2010
- CYP3A5*3 Genotype Associated With Intrasubject Pharmacokinetic Variation Toward Tacrolimus in Bioequivalence StudyTherapeutic Drug Monitoring, 2010
- Calcineurin Inhibitor Minimization in the Symphony Study: Observational Results 3 Years after TransplantationAmerican Journal of Transplantation, 2009
- RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATIONTransplantation, 1996
- AN OPEN-LABEL, CONCENTRATION-RANGING TRIAL OF FK506 IN PRIMARY KIDNEY TRANSPLANTATIONTransplantation, 1996
- A Risk-Benefit Assessment of Tacrolimus in TransplantationDrug Safety, 1995